An in-vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression

Brain Research

Volumn 879, Issue 1-2, 2000, Pages 193-199

  Wrynn, Aileen S ^a,b   Mac Sweeney, Clíona P ^a   Franconi, Florence ^c   Lemaire, Laurent ^d   Pouliquen, Daniel ^d   Herlidou, Sandra ^e   Leonard, Brian E ^b   Gandon, Jean Marc ^a   De Certaines, Jacques D ^e  

^a Biotrial SA   (France)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c UNIVERSITÉ D'ANGERS   (France)

^d Universite d'Angers   (France)

^e CS 34317   (France)

Author keywords

Animal model of depression; Degeneration; Disorders of the nervous system; MRI; Neuropsychiatric disorders; Olfactory bulbectomy; Ventricular enlargement

Indexed keywords

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN DEGENERATION; BRAIN REGION; BRAIN VENTRICLE DILATATION; CONTROLLED STUDY; DEPRESSION; HIPPOCAMPUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY BULBECTOMY; PRIORITY JOURNAL; RAT;

AMYGDALA; ANIMALS; BRAIN; CAUDATE NUCLEUS; CEREBRAL CORTEX; CEREBRAL VENTRICLES; DEPRESSION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MAGNETIC RESONANCE IMAGING; OLFACTORY BULB; RATS; REFERENCE VALUES;

EID: 0034613330     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02619-6     Document Type: Article

References (20)

1. Brunjes P.C. Lessons from lesions: the effects of olfactory bulbectomy. Chem. Senses. 17:1992;729-763.
2. Drevets W.C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annu. Rev. Med. 49:1998;341-361.
3. Grecksch G., Zhou D., Franke C., Schröder U., Bernhard S., Becker A., Huether G. Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates. Br. J. Pharmacol. 122:1997;1725-1731.
4. Jesberger J.A., Richardson J.S. Animal models of depression: parallels and correlates to severe depression in humans. Biol. Psychol. 20:1985;764-784.
5. Kellner C.H., Rubinow D.R., Post R.M. Cerebral ventricular size and cognitive impairment in depression. J. Affect. Disord. 10:1986;215-219.
6. Kelly J.P., Wrynn A.S., Leonard B.E. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol. Ther. 75:1997;1-17.
7. Kitayama I., Yaga T., Kayahara T., Nakano K., Murase S., Otani M., Nomura J. Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biol. Psychol. 42:1997;687-696.
8. LeMay L.G., Vander A.J., Kluger M.J. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol. Behav. 47:1990;957-961.
9. Lumia A.R., Teicher M.H., Salchli F., Ayers E., Possidente B. Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res. 587:1992;181-185.
10. Pitts A.F., Carroll B.T., Gehris T.L., Kathol R.G. Elevated CSF protein in male patients with depression. Biol. Psychiatry. 28:1990;629-637.
11. Pouliquen D., Chouly C. Magnetic microcarriers for medical applications. Arshady R. Microspheres, Microcapsules and Liposomes. Vol. 2:1998;339-378 Citus Press, London.
12. Rajowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H., Overholser J.C., Roth B.L., Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry. 45:1999;1085-1098.
13. Rowland L.P. Blood-brain barrier, cerebrospinal fluid, brain edema, and hydrocephalus. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science. 2nd ed. 1991;837-844 Elsevier, New York.
14. Sharma H.S., Cervos-Navarro J., Dey P.K. Increased blood-brain barrier permeability following acute short-term forced swimming exercise in conscious normotensive young rats. Neurosci. Res. 10:1991;211-221.
15. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J. Neurosci. 19:1999;5034-5043.
16. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effects of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56:1997;131-137.
17. Soares J.C., Mann J.J. The anatomy of mood disorders - review of structural neuroimaging studies. Biol. Psychiatry. 41:1997;86-106.
18. Song C., Leonard B.E. Serotonin reuptake inhibitors reverse the impairments in behaviour, neurotransmitter and immune functions in the olfactory bulbectomized rat. Hum. Psychopharmacol. 9:1994;135-146.
19. Videbech P. MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatr. Scand. 96:1997;157-168.
20. Wrynn A.S., Sebens J.B., Koch T., Leonard B.E., Korf J. Prolonged c-jun expression in the basolateral amygdala following bulbectomy: possible implications for antidepressant activity and time of onset. Mol. Brain Res. 76:2000;7-17.